MarketPulse
F

$FOLD

3 articles found
1 positive
2 negative
0 neutral
The Motley FoolThe Motley Fool··Cory Renauer

CIBRA Capital Doubles Down on Amicus Therapeutics Merger Arbitrage Play

CIBRA Capital increases Amicus Therapeutics stake to 11.78% of AUM, betting on BioMarin's $14.50 acquisition for $0.20 per share profit.
FOLDBMRNacquisition13F filing
GlobeNewswire Inc.GlobeNewswire Inc.··Halper Sadeh Llc

Law Firm Launches Shareholder Protection Review of Four Merger Transactions

Law firm Halper Sadeh launches investigations into four merger deals involving RAPT Therapeutics, Contigo Software, TBNK Therapeutics, and Fold Health to ensure fair shareholder treatment.
RAPTCTGOTBNFOLDsecurities fraudshareholder rights
GlobeNewswire Inc.GlobeNewswire Inc.··Monteverde & Associates Pc

Law Firm Urges Shareholders to Review Four Pending M&A Transactions Ahead of 2026 Votes

Law firm investigates four M&A deals for RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore ahead of March 2026 shareholder votes.
RAPTCTGOTBNFOLDacquisitionclass action